Controlling Hyperglycemia Among Minority Population (CHAMP)

S

Sinai Health System

Status

Completed

Conditions

Diabetes

Treatments

Behavioral: Community health worker education
Behavioral: Cell phone text messaging

Study type

Interventional

Funder types

Other

Identifiers

NCT02681718
MSH15-46

Details and patient eligibility

About

The purpose of this study is to compare the efficacy of three approaches in diabetes management: (1) community health worker (CHW) education; (2) text messaging; and (3) usual hospital-based care. The goal is to determine the most cost-effective method of diabetes management among an economically-disadvantaged, minority population.

Full description

The CHAMP study will test the efficacy of two interventions designed to decrease uncontrolled hyperglycemia (defined as Hemoglobin-A1C (A1C) at or above 9%) among adults with diabetes. Patients from a safety-net hospital will be randomized into three groups: 1) a control group, 2) an intervention providing diabetes self-care text messages, or 3) an intervention using community health workers to provide diabetes education and linkage to care. Secondary objectives include increasing diabetes knowledge, improving diabetes self-management, and increasing use of primary care (i.e., make one visit to the physician in 6 months) among the intervention participants. A cost-effectiveness analysis will determine the most appropriate way to reduce the burden of uncontrolled diabetes.

Enrollment

272 patients

Sex

All

Ages

18 to 64 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

*Hyperglycemia with A1C ≥9%

Exclusion criteria

  • Lives greater than 20 miles driving distance from Mount Sinai Hospital
  • Pregnant women with gestational diabetes
  • Advanced end-organ complications due to diabetes that include: end-stage renal disease, stroke with paresis, Congestive Heart Failure (NYHA class III or IV), or other major end-organ complication of diabetes
  • Receiving treatment for a major psychiatric disorder (i.e. schizophrenia)
  • Unable to understand and give informed consent in either English or Spanish
  • Currently or previously participated in a diabetes research study
  • Family member currently enrolled in a diabetes research study
  • Previously received diabetes care related cell phone text messages
  • Unable to receive text messages 3-4 times per week
  • Living in a homeless shelter or temporary housing
  • Plans to travel outside of the United States for more than 3 months in next year

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

272 participants in 3 patient groups

Community Health Worker education
Experimental group
Description:
During a six-month intervention period, the CHWs will conduct six home-based visitations and provide individualized diabetes education using an intensive diabetes lifestyle curriculum called Diabetes Learning Circle (DLC), developed and used by the Sinai Diabetes Education Program. At each visit, lasting for approximately one hour, the participants will be motivated to set SMART behavioral goals for diabetes self-management. At each visit after the initial visit, CHWs will follow-up with each participant to check their progress on their behavioral SMART goals. In addition, the CHWs will conduct intermittent phone calls (at least one monthly) and home visits as needed.
Treatment:
Behavioral: Community health worker education
Cell phone text messaging
Experimental group
Description:
The participants in the text messaging group will receive weekly text messages through CareMessage. Each participant will receive 3-4 text messages per week for 6 months.
Treatment:
Behavioral: Cell phone text messaging
Control
No Intervention group
Description:
The participants in the control group will receive education as determined by the hospital's diabetes educator, dietitian, physician, or the participant's managed care provider. No additional education will be provided by the research team.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems